NCT04272034 2025-10-16Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated105 enrolled
NCT06034860 2024-11-01Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesMolecular Templates, Inc.Phase 1 Terminated15 enrolled